Tata Elxsi has been selected by Skanray as a strategic partner for the development of software platforms and core technologies for improved surgical imaging. Through the use of cutting-edge technological modules, our partnership seeks to transform diagnosis and treatment by enhancing their predictability, accuracy, and consistency.
Skanray is aggressively working toward a long-term goal of adding new device families and modalities to its portfolio. The goal of this project is to create a cloud platform for advanced analytics in addition to a set of reusable medical device modules and parts.
In order to ensure interoperability, compatibility, and multi-modal capability, Tata Elxsi will spearhead a software platform-led approach to diagnostics that will support all imaging, critical care, and surgical devices from the Skanray family. The newest innovations in technology and process optimization from AI and GenAI will also be integrated into this platform.
Skanray has the opportunity to completely reimagine the medical technology landscape with cutting-edge, modular, and reasonably priced diagnostics systems by combining its knowledge of medical devices, core component technology, systems, and applications with Tata Elxsi’s domain expertise in medical imaging, software platform development, digital capabilities in cloud, AI, and analytics, and ready-to-use solution accelerators.
Pankaj Madhukar Wani, Head of Healthcare Business Unit at Tata Elxsi said, “The diagnostic imaging landscape is being transformed by software and digital technologies such as cloud and AI. We are delighted to be supporting Skanray in realising their long-term strategy and vision for healthcare. This long-term partnership will help create transformative solutions for healthcare facilities and patients worldwide.”
